Showing results (241-250 of 262) with videos related to
Sort By:
Pageof 27
Scientific Reports|April 5, 2017
Protein S Heerlen mutation heterozygosity is associated with venous thrombosis riskP Suchon, M Germain, A Delluc, et al.International Immunology|October 1, 1993
Maturation of human myelomonocytic leukemia cells following ligation of the low affinity receptor for IgE (Fc epsilon RII/CD23)F Ouaaz, N Paul-Eugène, M Arock, et al.Leukemia & Lymphoma|October 1, 1996
A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 casesC Soussain, H Merle-Béral, I Reux, et al.Blood|November 15, 1996
High frequency of somatic mutations in the VH genes expressed in prolymphocytic leukemiaF Davi, K Maloum, A Michel, et al.Journal of Interventional Cardiology|June 11, 2002
Patent foramen ovale closure in patients with transient ischemia attack/strokeH Sievert, K Horvath, E Zadan, et al.The Journal of Clinical Investigation|September 1, 1992
Interleukin-7 is a growth factor for Sézary lymphoma cellsA Dalloul, L Laroche, M Bagot, et al.Leukemia|December 1, 1995
Lack of evidence of HTLV-I/II infection in T CD8 malignant or reactive lymphoproliferative disorders in France: a serological and/or molecular study of 169 casesN Fouchard, B Flageul, M Bagot, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
IL-4 release by human leukemic and activated normal basophilsM Arock, H Merle-Béral, B Dugas, et al.Blood Cancer Journal|September 11, 2012
Waldenström's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disordersA Perrot, C Pionneau, N Azar, et al.Ocular Immunology and Inflammation|March 23, 2001
Ocular and central nervous system lymphoma: clinical features and diagnosisN Cassoux, H Merle-Beral, V Leblond, et al.Pageof 27